BMPR2 and pulmonary arterial hypertension: These studies indicate that delivery of exogenous BMPR2 to the pulmonary vascular endothelium can improve cardiopulmonary parameters in two different rodent models of PAH, in some cases on a preventive basis and in other cases therapeutically.